A novel thioredoxin reductase inhibitor inhibits cell growth and induces apoptosis in HL-60 and K562 cells

被引:14
作者
Peng, Zuo-fu [1 ]
Lan, Lin-xiang [1 ]
Zhao, Fang [1 ]
Li, Jing [1 ]
Tan, Qiang [2 ]
Yin, Han-wei [3 ]
Zeng, Hui-hui [1 ]
机构
[1] Peking Univ, Sch Pharmaceut Sci, Dept Biol Chem, Beijing 100083, Peoples R China
[2] Peking Univ First Hosp, Dept Geriatr Med, Beijing 100034, Peoples R China
[3] Peking Univ, Coll Life Sci, Beijing 100075, Peoples R China
基金
中国国家自然科学基金;
关键词
thioredoxin reductase (TrxR); novel TrxR inhibitor; 1,2-[bis(1,2-benzisoselenazolone-3(2H)-ketone)]ethane (BBSKE); apoptosis;
D O I
10.1631/jzus.B071605
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human thioredoxin reductase (TrxR) system is associated with cancer cell growth and anti-apoptosis process. Effects of 1,2-[bis(1,2-benzisoselenazolone-3(2H)-ketone)]ethane (BBSKE), a novel TrxR inhibitor, were investigated on human leukemia cell lines HL-60 and K562. BBSKE treatment induced cell growth inhibition and apoptosis in both cell lines. Apoptosis induced by BBSKE is through Bcl-2/Bax and caspase-3 pathways. Ehrlich's ascites carcinoma-bearing mice were used to investigate the anti-tumor effect of BBSKE in vivo. Tumor-bearing mice treated with BBSKE showed an increase of life span with a comparable effect to cyclophosphamide (CTX). These results suggest a potential usage of BBSKE as a therapeutic agent against non-solid tumors.
引用
收藏
页码:16 / 21
页数:6
相关论文
共 27 条
[1]   POTENTIAL ANTI-TUMOR AGENTS .9. SYNTHESIS AND ANTI-TUMOR ACTIVITY OF 2 ANALOGS OF KETOCAINE [J].
ANDREANI, A ;
SCAPINI, G ;
GALATULAS, I ;
BOSSA, R .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (07) :814-815
[2]   Thioredoxin, thioredoxin reductase and tumour necrosis factor-α expression in melanoma cells:: correlation to resistance against cytotoxic attack [J].
Barral, AM ;
Källström, R ;
Sander, B ;
Rosén, A .
MELANOMA RESEARCH, 2000, 10 (04) :331-343
[3]   Drug-resistant human lung cancer cells are more sensitive to selenium cytotoxicity -: Effects on thioredoxin reductase and glutathione reductase [J].
Björkhem-Bergman, L ;
Jönsson, K ;
Eriksson, LC ;
Olsson, JM ;
Lehmann, S ;
Paul, C ;
Björnstedt, M .
BIOCHEMICAL PHARMACOLOGY, 2002, 63 (10) :1875-1884
[4]  
CHAE HZ, 1994, J BIOL CHEM, V269, P27670
[5]  
COLIGAN JE, 1997, CURRENT PROTOCOLS IM
[6]   AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1 [J].
Hirota, K ;
Matsui, M ;
Iwata, S ;
Nishiyama, A ;
Mori, K ;
Yodoi, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) :3633-3638
[7]  
HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.biochem.54.1.237
[8]  
Kahlos K, 2001, INT J CANCER, V95, P198, DOI 10.1002/1097-0215(20010520)95:3<198::AID-IJC1034>3.0.CO
[9]  
2-F
[10]  
Kakolyris S, 2001, CLIN CANCER RES, V7, P3087